KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuancesShort-Term Debt repayments
Ratios

Elevance Health (ELV) Accumulated Depreciation & Amortization (2016 - 2025)

Elevance Health (ELV) has disclosed Accumulated Depreciation & Amortization for 17 consecutive years, with $4.1 billion as the latest value for Q4 2025.

  • Quarterly Accumulated Depreciation & Amortization rose 10.31% to $4.1 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $4.1 billion through Dec 2025, up 10.31% year-over-year, with the annual reading at $4.1 billion for FY2025, 10.31% up from the prior year.
  • Accumulated Depreciation & Amortization for Q4 2025 was $4.1 billion at Elevance Health, up from $3.7 billion in the prior quarter.
  • The five-year high for Accumulated Depreciation & Amortization was $4.3 billion in Q4 2021, with the low at $2.8 billion in Q4 2022.
  • Average Accumulated Depreciation & Amortization over 5 years is $3.7 billion, with a median of $3.7 billion recorded in 2024.
  • The sharpest move saw Accumulated Depreciation & Amortization tumbled 35.41% in 2022, then rose 26.44% in 2023.
  • Over 5 years, Accumulated Depreciation & Amortization stood at $4.3 billion in 2021, then tumbled by 35.41% to $2.8 billion in 2022, then grew by 26.44% to $3.5 billion in 2023, then grew by 3.75% to $3.7 billion in 2024, then grew by 10.31% to $4.1 billion in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $4.1 billion, $3.7 billion, and $3.5 billion for Q4 2025, Q4 2024, and Q4 2023 respectively.